Akonni Wins $435K SBIR Grant to Develop POC Tuberculosis Dx on PCR Array Technology
July 29, 2010
Akonni Wins $435K SBIR Grant to Develop POC Tuberculosis Dx on PCR Array Technology
In addition, Akonni is developing tests based on the biochip technology for a number of other infectious agents, and is designing and testing an integrated instrument platform to perform the tests, with the ultimate goal of seeking US regulatory clearance.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Akonni's $3M Grant Latest in String of NIH Awards for PCR Array-Based Infectious Disease Dxs
September 30, 2010 / PCR Insider - Akonni Biosystems Licenses USAMRIID IP to Develop Molecular Tests for Biothreat Agents
February 10, 2011 / PCR Insider - Product Watch: Akonni Biosystems and Sage Science
January 17, 2013 / PCR Insider - Dx Focus: Akonni TruDiagnosis Studies; Spartan Bio CYP2C19 Test; Mitomics Prostate Cancer Assay
January 10, 2013 / PCR Insider - Product Watch: Akonni TruTip and Illumina TruSeq Sample Prep Kits
September 20, 2012 / PCR Insider